Department of Biomedical Engineering, Marquette University and Medical College of Wisconsin, Milwaukee, Wisconsin.
Department of Medicine, Medical College of Wisconsin and Zablocki Veterans Affairs Medical Center, Milwaukee, Wisconsin.
J Am Soc Nephrol. 2022 Aug;33(8):1602-1612. doi: 10.1681/ASN.2021101353. Epub 2022 Jul 1.
Patients with kidney failure treated with hemodialysis (HD) may be at risk for cerebral hypoperfusion due to HD-induced BP decline in the setting of impaired cerebral autoregulation. Cerebrovascular reactivity (CVR), the cerebrovascular response to vasoactive stimuli, may be a useful indicator of cerebral autoregulation in the HD population and identify those at risk for cerebral hypoperfusion. We hypothesize that CVR combined with intradialytic BP changes will be associated with declines in cerebral oxygenation saturation (ScO) during HD.
Participants completed the MRI scans on a non-HD day and cerebral oximetry during HD. We measured CVR with resting-state fMRI (rs-fMRI) without a gas challenge and ScO saturation with near-infrared spectroscopy. Regression analysis was used to examine the relationship between intradialytic cerebral oxygen desaturation, intradialytic BP, and CVR in different gray matter regions.
Twenty-six patients on HD had complete data for analysis. Sixteen patients were men, 18 had diabetes, and 20 had hypertension. Mean±SD age was 65.3±7.2 years, and mean±SD duration on HD was 11.5±9.4 months. CVR in the anterior cingulate gyrus (ACG; =0.03, =0.19) and insular cortex (IC; =0.03, =0.19) regions negatively correlated with decline in intradialytic ScO. Model prediction of intradialytic ScO improved when including intradialytic BP change and ultrafiltration rate to the ACG rsCVR (<0.01, =0.48) and IC rsCVR (=0.02, =0.35) models, respectively.
We found significant relationships between regional rsCVR measured in the brain and decline in intradialytic ScO. Our results warrant further exploration of using CVR in determining a patient's risk of cerebral ischemic injury during HD.
接受血液透析(HD)治疗的肾衰竭患者可能存在脑灌注不足的风险,原因是 HD 引起的血压下降和受损的脑自动调节功能。脑血管反应性(CVR)是血管活性刺激对脑血管的反应,可能是 HD 人群脑自动调节的有用指标,并可识别发生脑灌注不足的风险。我们假设 CVR 与透析期间的血压变化相结合,将与 HD 期间脑氧饱和度(ScO)的下降相关。
参与者在非 HD 日完成 MRI 扫描和 HD 期间的脑氧饱和度监测。我们使用静息状态 fMRI(rs-fMRI)测量 CVR,无需进行气体挑战,使用近红外光谱测量 ScO 饱和度。回归分析用于检查不同灰质区域的透析期间脑氧去饱和、透析期间血压和 CVR 之间的关系。
26 名接受 HD 治疗的患者完成了数据分析。16 名患者为男性,18 名患有糖尿病,20 名患有高血压。平均年龄为 65.3±7.2 岁,HD 治疗时间的平均±SD 为 11.5±9.4 个月。前扣带皮层(ACG; =0.03, =0.19)和岛叶皮层(IC; =0.03, =0.19)区域的 CVR 与透析期间 ScO 的下降呈负相关。当将透析期间的血压变化和超滤率纳入到 ACG rsCVR(<0.01, =0.48)和 IC rsCVR(=0.02, =0.35)模型时,透析期间 ScO 的模型预测得到了改善。
我们发现大脑中测量的区域 rsCVR 与透析期间 ScO 的下降之间存在显著关系。我们的结果值得进一步探索在 HD 期间使用 CVR 来确定患者发生脑缺血性损伤的风险。